275 related articles for article (PubMed ID: 28656373)
21. Sensitivity of CE-MRI in detecting local recurrence after radical prostatectomy.
Coppola A; Platania G; Ticca C; De Mattia C; Bortolato B; Palazzi MF; Vanzulli A
Radiol Med; 2020 Jul; 125(7):683-690. PubMed ID: 32078119
[TBL] [Abstract][Full Text] [Related]
22. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.
Do T; Parker RG; Do C; Tran L; Do L; Dolkar D
Cancer J Sci Am; 1998; 4(5):324-30. PubMed ID: 9815297
[TBL] [Abstract][Full Text] [Related]
23. Early salvage radiation therapy combined with short-term hormonal therapy in recurrent prostate cancer after radical prostatectomy: single-institution 4-year data on outcome, toxicity, health-related quality of life and co-morbidities from 184 consecutive patients treated with 70 Gy.
Cortés-González JR; Castellanos E; Sandberg K; Eriksson MH; Wiklund P; Carlsson S; Cohn-Cedermark G; Harmenberg U; Gustafsson O; Levitt SH; Lennernäs B; Brandberg Y; Márquez M; Kälkner KM; Nilsson S
Int J Oncol; 2013 Jan; 42(1):109-17. PubMed ID: 23151842
[TBL] [Abstract][Full Text] [Related]
24. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
[TBL] [Abstract][Full Text] [Related]
25. Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer.
Souvatzoglou M; Krause BJ; Pürschel A; Thamm R; Schuster T; Buck AK; Zimmermann F; Molls M; Schwaiger M; Geinitz H
Radiother Oncol; 2011 May; 99(2):193-200. PubMed ID: 21620494
[TBL] [Abstract][Full Text] [Related]
26. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
[TBL] [Abstract][Full Text] [Related]
27. Salvage low-dose-rate brachytherapy for prostate cancer local recurrence after radical prostatectomy: our first three patients.
Gastaldi E; Gallo F; Chiono L; Giberti C
Urologia; 2014; 81(1):46-50. PubMed ID: 24474541
[TBL] [Abstract][Full Text] [Related]
28. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?
Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT
Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626
[TBL] [Abstract][Full Text] [Related]
29. Salvage radiation therapy following radical prostatectomy. A national Danish study.
Ervandian M; Høyer M; Petersen SE; Sengeløv L; Hansen S; Holmberg M; Sveistrup J; Meidahl Petersen P; Borre M
Acta Oncol; 2016 May; 55(5):598-603. PubMed ID: 26399602
[TBL] [Abstract][Full Text] [Related]
30. Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy.
Geinitz H; Riegel MG; Thamm R; Astner ST; Lewerenz C; Zimmermann F; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1930-7. PubMed ID: 21514736
[TBL] [Abstract][Full Text] [Related]
31. Dose-adapted salvage radiotherapy after radical prostatectomy based on an erMRI target definition model: toxicity analysis.
Zilli T; Jorcano S; Peguret N; Caparrotti F; Hidalgo A; Khan HG; Vees H; Weber DC; Miralbell R
Acta Oncol; 2014 Jan; 53(1):96-102. PubMed ID: 24032443
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors after salvage radiotherapy alone in patients with biochemical recurrence after radical prostatectomy.
Song W; Jeon HG; Sung HH; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
Int J Urol; 2016 Jan; 23(1):56-61. PubMed ID: 26502086
[TBL] [Abstract][Full Text] [Related]
33. GATA2 expression and biochemical recurrence following salvage radiation therapy for relapsing prostate cancer.
Robinson JL; Tzou KS; Parker AS; Heckman MG; Wu KJ; Hilton TW; Pisansky TM; Schild SE; Peterson JL; Vallow LA; Buskirk SJ
Br J Radiol; 2017 Jul; 90(1075):20170174. PubMed ID: 28486040
[TBL] [Abstract][Full Text] [Related]
34. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
[TBL] [Abstract][Full Text] [Related]
35. [11C]Choline-PET/CT for outcome prediction of salvage radiotherapy of local relapsing prostate carcinoma.
Reske SN; Moritz S; Kull T
Q J Nucl Med Mol Imaging; 2012 Oct; 56(5):430-9. PubMed ID: 23069922
[TBL] [Abstract][Full Text] [Related]
36. PET/CT and MRI directed extended salvage radiotherapy in recurrent prostate cancer with lymph node metastases.
Rischke HC; Eiberger AK; Volegova-Neher N; Henne K; Krauss T; Grosu AL; Jilg CA
Adv Med Sci; 2016 Sep; 61(2):212-218. PubMed ID: 26895459
[TBL] [Abstract][Full Text] [Related]
37. Brachytherapy for the treatment of recurrent prostate cancer after radiotherapy or radical prostatectomy.
Gomez-Veiga F; Mariño A; Alvarez L; Rodriguez I; Fernandez C; Pertega S; Candal A
BJU Int; 2012 Feb; 109 Suppl 1():17-21. PubMed ID: 22239225
[TBL] [Abstract][Full Text] [Related]
38. Postoperative radiotherapy after radical prostatectomy for prostate carcinoma: the experience of the Brescia Radium Institute.
Caraffini B; De Stefani A; Vitali E; Magri E; Tonoli S; Frata P; Gatta R; Magrini SM
Radiol Med; 2006 Aug; 111(5):741-7. PubMed ID: 16721508
[TBL] [Abstract][Full Text] [Related]
39. The prognostic value, sensitivity, and specificity of multiparametric magnetic resonance imaging before salvage radiotherapy for prostate cancer.
Breen WG; Stish BJ; Harmsen WS; Froemming AT; Mynderse LA; Choo CR; Davis BJ; Pisansky TM
Radiother Oncol; 2021 Aug; 161():9-15. PubMed ID: 34023327
[TBL] [Abstract][Full Text] [Related]
40. Postoperative radiotherapy after upfront radical prostatectomy: debated issues at a turning point-a survey exploring management trends on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology).
Francolini G; Timon G; Matrone F; Marvaso G; Nicosia L; Ognibene L; Vinciguerra A; Trodella LE; Franzese C; Borghetti P; Jereczek-Fossa BA; Arcangeli S
Clin Transl Oncol; 2021 Dec; 23(12):2568-2578. PubMed ID: 34286475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
